vimarsana.com

Page 18 - தொகுக்கப்பட்டு மொத்தம் வருமானம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bank of Baroda share price: Neutral on Bank of Baroda, target price Rs 85: Motilal Oswal

Motilal Oswal has neutral call on Bank of Baroda with a target price of Rs 85. The current market price of Bank of Baroda is Rs 80.5. Bank of Baroda, incorporated in the year 1911, is a banking company (having a market cap of Rs 41758.75 Crore). Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 23762.09 Crore, up 7.66 % from last quarter Total Income of Rs 22070.52 Crore and up 5.19 % from last year same quarter Total Income of Rs 22589.84 Crore. The bank reported net profit after tax of Rs -740.79 Crore in latest quarter. Collection efficiency improves to 93%, but remains lower v/s other peers. On the asset quality front, GNPA/NNPA ratio improved v/s pro forma GNPA/NNPA as of De’20. Total restructuring stood ~1.3% of advances (INR94b), while SMA-1/2 stood at 3.9% of loans. The brokerage remains watchful of the impact of the second COVID wave on asset quality and estimate credit cost to stay elevated at 2.1% for FY22E

Ipca Laboratories share price: Buy Ipca Laboratories, target price Rs 2400: Motilal Oswal

Motilal Oswal has buy call on Ipca Laboratories Ltd. with a target price of Rs 2400. The current market price of Ipca Laboratories Ltd. is Rs 2066.05. Time period given by analyst is one year when Ipca Laboratories Ltd. price can reach defined target. Ipca Laboratories Ltd., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 26410.61 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 1134.58 Crore, down -20.39 % from last quarter Total Income of Rs 1425.21 Crore and up 4.33 % from last year same quarter Total Income of Rs 1087.49 Crore. Company reported net profit after tax of Rs 163.70 Crore in latest quarter.

PNB Housing Finance share price: Buy PNB Housing Finance, target price Rs 678: ICICI Securities

ICICI Securities has buy call on PNB Housing Finance with a target price of Rs 678. The current market price of PNB Housing Finance Ltd. is Rs 630.2. Time period given by analyst is one year when PNB Housing Finance Ltd. price can reach defined target. PNB Housing Finance Ltd., incorporated in the year 1988, is a Mid Cap company (having a market cap of Rs 8845.01 Crore) operating in NBFC sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 1833.90 Crore, down -3.29 % from last quarter Total Income of Rs 1896.35 Crore and down -6.04 % from last year same quarter Total Income of Rs 1951.84 Crore. Company reported net profit after tax of Rs 127.03 Crore in latest quarter.

kaveri seed share price: Buy Kaveri Seed Company, target price Rs 830: Motilal Oswal

Motilal Oswal has buy call on Kaveri Seed Company with a target price of Rs 830. The current market price of Kaveri Seed Company Ltd. is Rs 710.05. Time period given by analyst is one year when Kaveri Seed Company price can reach defined target. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 68.48 Crore, down -45.69 % from last quarter Total Income of Rs 126.10 Crore and down -27.22 % from last year same quarter Total Income of Rs 94.10 Crore. Company reported net profit after tax of Rs -17.77 Crore in latest quarter. KSCL is on track to diversify from sales of cotton seeds by increasing the share of rice and vegetables (contribution of non-cotton seed sales to overall sales has increased to 58% in FY21 v/s 52% in FY20), which are growing at a faster pace and yielding a higher margin (v/s the Cotton segment)

Aurobindo Pharma share price: Buy Aurobindo Pharma, target price Rs 1150: Motilal Oswal

Motilal Oswal has buy call on Aurobindo Pharma with a target price of Rs 1150. The current market price of Aurobindo Pharma is Rs 984.5. Time period given by analyst is year when Aurobindo Pharma price can reach defined target. Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 57597.77 Crore) operating in Pharmaceuticals sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 6079.60 Crore, down -6.44 % from last quarter Total Income of Rs 6498.31 Crore and down -1.80 % from last year same quarter Total Income of Rs 6191.02 Crore. Company reported net profit after tax of Rs 809.55 Crore in latest quarter.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.